AU2002221129A1 - Triglyceride depressant composition - Google Patents
Triglyceride depressant compositionInfo
- Publication number
- AU2002221129A1 AU2002221129A1 AU2002221129A AU2112902A AU2002221129A1 AU 2002221129 A1 AU2002221129 A1 AU 2002221129A1 AU 2002221129 A AU2002221129 A AU 2002221129A AU 2112902 A AU2112902 A AU 2112902A AU 2002221129 A1 AU2002221129 A1 AU 2002221129A1
- Authority
- AU
- Australia
- Prior art keywords
- depressant composition
- triglyceride
- triglyceride depressant
- composition
- depressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000383051 | 2000-12-18 | ||
JP2000-383051 | 2000-12-18 | ||
PCT/JP2001/010912 WO2002049640A1 (fr) | 2000-12-18 | 2001-12-12 | Composition servant a faire baisser le taux de triglycerides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002221129A1 true AU2002221129A1 (en) | 2002-07-01 |
Family
ID=18850773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002221129A Abandoned AU2002221129A1 (en) | 2000-12-18 | 2001-12-12 | Triglyceride depressant composition |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040009986A1 (zh) |
JP (1) | JP4212272B2 (zh) |
CN (1) | CN1307990C (zh) |
AU (1) | AU2002221129A1 (zh) |
CA (1) | CA2432035A1 (zh) |
HK (1) | HK1061202A1 (zh) |
TW (1) | TWI284529B (zh) |
WO (1) | WO2002049640A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05000050A (es) * | 2002-07-03 | 2005-04-08 | Esperion Therapeutics Inc | Composiciones farmaceuticas y metodos para tratar, prevenir y manejar el colesterol, dislipidemia y enfermedades relacionadas. |
JP2005187454A (ja) * | 2003-12-05 | 2005-07-14 | Sankyo Co Ltd | ビタミンe含有ldl低下剤及び/又は動脈硬化抑制剤組成物 |
US20050192347A1 (en) * | 2003-12-23 | 2005-09-01 | Dasseux Jean-Louis H. | Urea and thiourea compounds and compositions for cholesterol management and related uses |
SG155189A1 (en) * | 2004-08-06 | 2009-09-30 | Transform Pharmaceuticals Inc | Novel fenofibrate formulations and related methods of treatment |
US20090042979A1 (en) * | 2004-08-06 | 2009-02-12 | Transform Pharmaceuticals Inc. | Novel Statin Pharmaceutical Compositions and Related Methods of Treatment |
KR20070038553A (ko) * | 2004-08-06 | 2007-04-10 | 트렌스폼 파마수티컬스 인코퍼레이티드 | 신규한 스타틴 약제학적 조성물 및 관련된 치료방법 |
KR101112549B1 (ko) * | 2005-01-31 | 2012-06-12 | 삼성전자주식회사 | 박막 트랜지스터 표시판 |
CN104799302A (zh) * | 2014-01-25 | 2015-07-29 | 天津中瑞药业股份有限公司 | 一种肌醇烟酸酯营养强化胶囊的制备方法 |
CN104799269A (zh) * | 2014-01-25 | 2015-07-29 | 天津中瑞药业股份有限公司 | 一种含硒的肌醇烟酸酯营养强化胶囊制备方法 |
US11547693B2 (en) | 2019-07-29 | 2023-01-10 | Matthias Rath | Ascorbate in the prevention of statin induced vascular calcification |
BR112022001422A2 (pt) | 2019-07-29 | 2022-03-22 | Matthias Rath | Ascorbato na prevenção da calcificação vascular induzida por estatina |
WO2022129003A1 (en) * | 2020-12-15 | 2022-06-23 | Dsm Ip Assets B.V. | Multiparticulate solid oral dosage form comprising statin and vitamin e |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019891B2 (ja) * | 1978-12-01 | 1985-05-18 | 第一製薬株式会社 | 薬物性脂肪肝用剤 |
JPS5869813A (ja) * | 1981-10-23 | 1983-04-26 | Sogo Yatsukou Kk | 血清脂質低下剤 |
JPS6041611A (ja) * | 1983-08-17 | 1985-03-05 | Sankyo Co Ltd | 血中脂質低下剤 |
US5260305A (en) * | 1988-12-12 | 1993-11-09 | E. R. Squibb & Sons, Inc. | Combination of pravastatin and nicotinic acid or related acid and method for lowering serum cholesterol using such combination |
US5662934A (en) * | 1993-01-05 | 1997-09-02 | Najarian; Thomas | Compositions and methods for lowering cholesterol while maintaining antioxidant levels |
JP2618202B2 (ja) * | 1994-06-23 | 1997-06-11 | 株式会社ロッテ | 血中脂質降下剤およびこれを含有する飲食品 |
US5798375A (en) * | 1995-07-03 | 1998-08-25 | Sankyo Company, Limited | Treatment of arteriosclerosis and xanthoma |
US5965621A (en) * | 1995-08-17 | 1999-10-12 | Allergan | Methods and compositions for reducing or maintaining body weight in a mammal |
AU732465B2 (en) * | 1996-04-17 | 2001-04-26 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
DE69837610T2 (de) * | 1997-07-31 | 2008-01-03 | Kos Life Sciences, Inc., Weston | Manteltablette enthaltend nikotinsäure oder einen stoff, der zu nikotinsäure metabolisiert wird in verzögert freigesetzter form und einen hmg-coa reduktasehemmer im mantel zur sofortigen freisetzung |
US6245797B1 (en) * | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
JP2000044470A (ja) * | 1998-08-04 | 2000-02-15 | Nof Corp | 高脂血症薬 |
CN1092986C (zh) * | 1999-08-16 | 2002-10-23 | 上海本草生物医学工程研究所 | 一种用于降血脂的辅酶a口服制剂及制备方法和应用 |
US6436406B1 (en) * | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
US6916849B2 (en) * | 2000-10-23 | 2005-07-12 | Sankyo Company, Limited | Compositions for improving lipid content in the blood |
CA2428204A1 (en) * | 2000-11-07 | 2002-05-16 | Sankyo Company, Limited | Lipid peroxide-lowering compositions |
US7037934B2 (en) * | 2000-12-14 | 2006-05-02 | Sankyo Company, Limited | Blood lipid ameliorant composition |
AU2002221131A1 (en) * | 2000-12-14 | 2002-06-24 | Sankyo Company Limited | Blood lipid ameliorant composition |
MXPA05000050A (es) * | 2002-07-03 | 2005-04-08 | Esperion Therapeutics Inc | Composiciones farmaceuticas y metodos para tratar, prevenir y manejar el colesterol, dislipidemia y enfermedades relacionadas. |
-
2000
- 2000-07-05 TW TW090131207A patent/TWI284529B/zh not_active IP Right Cessation
-
2001
- 2001-12-12 AU AU2002221129A patent/AU2002221129A1/en not_active Abandoned
- 2001-12-12 CA CA002432035A patent/CA2432035A1/en not_active Abandoned
- 2001-12-12 WO PCT/JP2001/010912 patent/WO2002049640A1/ja active Application Filing
- 2001-12-12 CN CNB018226949A patent/CN1307990C/zh not_active Expired - Fee Related
- 2001-12-14 JP JP2001380783A patent/JP4212272B2/ja not_active Expired - Fee Related
-
2003
- 2003-06-18 US US10/465,436 patent/US20040009986A1/en not_active Abandoned
-
2004
- 2004-06-15 HK HK04104302A patent/HK1061202A1/xx not_active IP Right Cessation
-
2006
- 2006-06-06 US US11/447,735 patent/US20060223811A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4212272B2 (ja) | 2009-01-21 |
US20060223811A1 (en) | 2006-10-05 |
US20040009986A1 (en) | 2004-01-15 |
CN1307990C (zh) | 2007-04-04 |
JP2002249431A (ja) | 2002-09-06 |
WO2002049640A1 (fr) | 2002-06-27 |
TWI284529B (en) | 2007-08-01 |
CA2432035A1 (en) | 2002-06-27 |
CN1489461A (zh) | 2004-04-14 |
HK1061202A1 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001292783A1 (en) | Antireflective composition | |
AU2001271027A1 (en) | Ester derivatives | |
AU2001262847A1 (en) | Language-understanding | |
AU2001282301A1 (en) | Fuel composition | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001230894A1 (en) | Pro-perfume composition | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2002241536A1 (en) | True-time delay generator | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001233145A1 (en) | Dispersant composition | |
AU2002221129A1 (en) | Triglyceride depressant composition | |
AU2001274593A1 (en) | Cold-setting composition | |
AU2001241098A1 (en) | Composition | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001246864A1 (en) | Hypotensors | |
AU2001287852A1 (en) | Composition | |
AU2001235764A1 (en) | Compositions | |
AU2002211741A1 (en) | Surface modifying composition | |
AU2001287732A1 (en) | Copolycarbonate-based composition | |
AUPR099200A0 (en) | New formulation | |
AU2001262711A1 (en) | Cytoprotectors |